News

The NIH's National Cancer Institute, which has long benefited from bipartisan support, now faces an exodus of clinicians and scientists.
Women who used at-home test kits were more than twice as likely to complete screening than those who received only telephone reminders.
Researchers in Europe and the U.S. have long collaborated to tackle tough scientific questions. Certain fields, like rare diseases, particularly benefit from international collaboration because it ...
Watch a Melanoma Research Alliance presentation by Alexandra-Chloe Villani about immunotherapy side effects in this skin cancer.
Scientists at the National Institutes of Health (NIH) have found that two common types of hormone therapy may alter breast cancer risk in women before age 55. Researchers discovered that women treated ...
The Food and Drug Administration (FDA) has loosened restrictions on CAR-T therapies for blood cancers, a move that is expected to make the revolutionary immunotherapy available to more people in more ...
Two tumor samples stained to highlight a molecular biomarker help differentiate between the two subtypes of pancreatic cancer. Red indicates the basal subtype; green indicates the classical subtype.
People diagnosed with localized prostate cancer are unlikely to die from the cancer if they are treated according to NCCN Guidelines.
Whole-genome sequencing study found air pollution to cause more cancer-related changes than secondhand smoke.
Watch Princess Kate, visiting a hospital in England, open up about recovering from cancer and putting on a brave face during treatment.
Conservative distrust of science helped set the stage for its dismantling. Can scientists bridge the partisan divide?
On July 2, 2025, the Food and Drug Administration granted accelerated approval to sunvozertinib (Zegfrovy, Dizal (Jiangsu) Pharmaceutical Co., Ltd.) for adult patients with locally advanced or ...